Tessera Stock

www.tesseratherapeutics.comBioTechFounded: 2018Funding to Date: $558.91MM

Tessera Therapeutics is a life sciences company developing Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source.

Register for Details

For more details on financing and valuation for Tessera, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Tessera.

Register Today

Other companies like Tessera in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$3.1B
Sector
Last Round Est. Valuation
$5.81B
Sector
Last Round Est. Valuation
$1.2B
Sector
Last Round Est. Valuation
$1.6B
Sector
Last Round Est. Valuation
$1.61B